Aclarion ACON 深 沪
等待开盘 10-06 09:30:00 美东时间
2.34
-0.040
-1.68%
华盛通- 最 高2.96
- 今 开2.35
- 成交量 3.32万股
- 最 低 2.25
- 昨 收 2.38
- 总市值 1680.28万
- 52周最高 12.03
- 市盈率 静 --
- 换手率 0.46%
- 52周最低 1.95
- 委 比 8.08%
- 总股本 718.07万
- 历史最高 585971.28
- 量 比 0.60
- 振 幅 29.83%
- 历史最低 1.95
- 每 手 1
- 风险率 1.90%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Profusa (NASDAQ:PFSA) stock increased by 112.5% to $4.36 during Thursday's pre-market session. The company's market cap stands at $1.2 million. GlucoTrack (NASDAQ:GCTK) stock rose 96.55% to $3.99. The
09-24 20:05
Aclarion Launches Market Access Program In Partnership With PRIA Healthcare
Partnership supports reimbursement strategy and U.S. commercial expansion for Aclarion's AI-driven platform for chronic low back pain.Program aims to follow successful reimbursement wins in the UK that are translating
06-09 19:04
Aclarion Partners With Institute of Neuro Innovation on Back Pain Technology
Aclarion, Inc., ("Aclarion" or the "Company") (NASDAQ:ACON, ACONW)), a commercial-stage healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms through
06-03 18:09
SentinelOne To Rally Nearly 40%? Here Are 10 Analyst Forecasts For Friday
Top Wall Street analysts changed outlook on top names. For full changes, see analyst ratings page. Stock targets and ratings also updated.
05-29 20:33
Aclarion Adds Lanman Spinal Neurosurgery As Clinical Site In CLARITY Trial
Lanman Spinal Neurosurgery is a leading spine-focused private practice recognized for its expertise in complex spinal procedures, early adoption of innovative technologies and high surgical volumeThe CLARITY randomized
05-07 18:09
Aclarion Announces $2.5M Buyback Plan
Aclarion, Inc., ("Aclarion" or the "Company") (NASDAQ:ACON, ACONW)), a commercial-stage healthcare technology company leveraging biomarkers and proprietary augmented intelligence (AI) algorithms through its
04-22 20:31
Aclarion Raises $10.4 Million, Sharpens Focus On Nociscan Rollout
Aclarion, Inc. (NASDAQ: ACON) closed a $10.4 million financing at $5.18/share, boosting balance sheet & extending cash runway to 2028.
01-13 23:51
Aclarion Raises $10.4M, Extends Cash Runway Into 2028
Aclarion, Inc., ("Aclarion" or the "Company") (NASDAQ:ACON, ACONW)), a commercial-stage healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help
01-13 19:01
Is the Market Bullish or Bearish on Aclarion Inc?
Aclarion Inc's (NYSE:ACON) short interest as a percent of float has risen 142.8...
01-10 02:00
Dow Edges Higher; US Economy Adds 50,000 Jobs In December
U.S. stocks traded higher this morning, with the Dow Jones index gaining around...
01-09 23:25
